Rothschild Investment LLC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.1M Buy
106,014
+6,666
+7% +$1.48M 1.21% 14
2025
Q4
$22.7M Sell
99,348
-2,453
-2% -$559K 1.25% 11
2025
Q3
$23.6M Sell
101,801
-293
-0.3% -$59.7K 1.33% 10
2025
Q2
$19M Sell
102,094
-2,114
-2% -$393K 1.19% 13
2025
Q1
$21.8M Sell
104,208
-2,832
-3% -$551K 1.46% 11
2024
Q4
$19M Sell
107,040
-1,214
-1% -$223K 1.25% 13
2024
Q3
$21.4M Sell
108,254
-2,260
-2% -$422K 1.4% 10
2024
Q2
$19M Sell
110,514
-8,389
-7% -$1.39M 1.32% 13
2024
Q1
$21.7M Sell
118,903
-360
-0.3% -$62K 1.57% 10
2023
Q4
$18.5M Sell
119,263
-8,390
-7% -$1.22M 1.55% 12
2023
Q3
$19M Buy
127,653
+1,740
+1% +$255K 1.61% 9
2023
Q2
$17M Sell
125,913
-5,769
-4% -$846K 1.41% 11
2023
Q1
$21M Buy
131,682
+985
+0.8% +$151K 1.84% 3
2022
Q4
$21.1M Buy
130,697
+2,454
+2% +$376K 1.94% 4
2022
Q3
$17.2M Buy
128,243
+597
+0.5% +$85.7K 1.7% 5
2022
Q2
$19.6M Sell
127,646
-6,138
-5% -$938K 1.8% 3
2022
Q1
$21.7M Sell
133,784
-16,076
-11% -$2.34M 1.7% 6
2021
Q4
$20.3M Sell
149,860
-10,404
-6% -$1.23M 1.57% 5
2021
Q3
$17.3M Sell
160,264
-8,546
-5% -$977K 1.45% 7
2021
Q2
$19M Sell
168,810
-7,790
-4% -$877K 1.51% 8
2021
Q1
$19.1M Sell
176,600
-1,180
-0.7% -$126K 1.65% 7
2020
Q4
$19M Sell
177,780
-40,616
-19% -$3.9M 1.84% 4
2020
Q3
$19.1M Buy
218,396
+12,047
+6% +$1.13M 2.08% 3
2020
Q2
$20.3M Buy
206,349
+406
+0.2% +$35.7K 2.44% 2
2020
Q1
$15.7M Sell
205,943
-11,469
-5% -$977K 2.05% 4
2019
Q4
$19.2M Sell
217,412
-425
-0.2% -$35.3K 1.91% 4
2019
Q3
$16.5M Buy
217,837
+4,773
+2% +$327K 1.92% 4
2019
Q2
$15.5M Buy
213,064
+28,163
+15% +$2.21M 1.83% 3
2019
Q1
$14.9M Sell
184,901
-153
-0.1% -$12.5K 1.75% 4
2018
Q4
$17.1M Buy
185,054
+5,759
+3% +$506K 2.28% 2
2018
Q3
$17M Buy
179,295
+12,462
+7% +$1.18M 2% 4
2018
Q2
$15.5M Buy
166,833
+22,974
+16% +$2.24M 1.95% 3
2018
Q1
$13.6M Sell
143,859
-32,327
-18% -$3.55M 1.74% 6
2017
Q4
$17M Sell
176,186
-16,547
-9% -$1.56M 1.85% 5
2017
Q3
$17.1M Buy
192,733
+4,610
+2% +$351K 1.94% 5
2017
Q2
$13.6M Buy
188,123
+1,717
+0.9% +$115K 1.55% 5
2017
Q1
$12.1M Sell
186,406
-18,077
-9% -$1.14M 1.41% 10
2016
Q4
$12.8M Buy
204,483
+11,255
+6% +$687K 1.54% 6
2016
Q3
$12.2M Sell
193,228
-12,593
-6% -$815K 1.49% 6
2016
Q2
$12.7M Sell
205,821
-4,315
-2% -$263K 1.63% 5
2016
Q1
$12M Buy
210,136
+6,540
+3% +$365K 1.54% 5
2015
Q4
$12.1M Sell
203,596
-1,125
-0.5% -$64.8K 1.54% 5
2015
Q3
$11.1M Buy
204,721
+1,037
+0.5% +$67.5K 1.47% 5
2015
Q2
$13.7M Sell
203,684
-14,650
-7% -$956K 1.59% 5
2015
Q1
$12.8M Buy
218,334
+421
+0.2% +$25.4K 1.5% 8
2014
Q4
$14.3M Sell
217,913
-1,625
-0.7% -$102K 1.7% 6
2014
Q3
$12.7M Sell
219,538
-17,971
-8% -$998K 1.54% 7
2014
Q2
$13.4M Sell
237,509
-672
-0.3% -$35.3K 1.71% 6
2014
Q1
$12.2M Buy
238,181
+4,996
+2% +$252K 1.65% 7
2013
Q4
$12.3M Sell
233,185
-15,500
-6% -$762K 1.68% 8
2013
Q3
$11.1M Sell
248,685
-1,651
-0.7% -$73.2K 1.64% 7
2013
Q2
$10.3M Buy
+250,336
New +$10.9M 1.68% 10

Other funds holding ABBV

Rothschild Investment LLC's ABBV Position: Q1 2026 in Review

Rothschild Investment LLC increased its AbbVie (ABBV) stake by 6.7% in Q1 2026, buying an estimated $1.48M and bringing the position to 106,014 shares worth $23.1M. The position accounts for 1.21% of the portfolio, ranked #14.

Rothschild Investment LLC first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.6M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Rothschild Investment LLC held 106,014 shares of AbbVie worth $23.1M as of Q1 2026.
  • Rothschild Investment LLC bought 6,666 AbbVie shares in Q1 2026, an estimated $1.48M.
  • AbbVie made up 1.21% of Rothschild Investment LLC's portfolio in Q1 2026, its #14 holding.
  • Rothschild Investment LLC first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Rothschild Investment LLC's AbbVie position peaked at $23.6M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.